113 related articles for article (PubMed ID: 11503384)
1. How does menopause alter the primary care of women?
Onega T
JAAPA; 2000 Apr; 13(4):42-4, 47-8, 51-4 passim. PubMed ID: 11503384
[No Abstract] [Full Text] [Related]
2. [Monitoring of postmenopausal women].
Ouzounian S; Chabbert-Buffet N
Rev Prat; 2005 Feb; 55(4):403-9. PubMed ID: 15828619
[TBL] [Abstract][Full Text] [Related]
3. Current evidence about the effect of hormone replacement therapy on the incidence of major conditions in postmenopausal women.
Beral V; Reeves G; Banks E
BJOG; 2005 Jun; 112(6):692-5. PubMed ID: 15924521
[No Abstract] [Full Text] [Related]
4. Postmenopausal hormone therapy in clinical perspective.
Hodis HN; Mack WJ
Menopause; 2007; 14(5):944-57. PubMed ID: 17353803
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
Thorp JM; Gavin NI; Ohsfeldt RL
Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
Calleja-Agius J; Brincat MP
Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
[TBL] [Abstract][Full Text] [Related]
7. Endometriosis: associations with menopause, hormone replacement therapy and cancer.
Palep-Singh M; Gupta S
Menopause Int; 2009 Dec; 15(4):169-74. PubMed ID: 19933470
[TBL] [Abstract][Full Text] [Related]
8. Outcomes ascertainment and adjudication methods in the Women's Health Initiative.
Curb JD; McTiernan A; Heckbert SR; Kooperberg C; Stanford J; Nevitt M; Johnson KC; Proulx-Burns L; Pastore L; Criqui M; Daugherty S;
Ann Epidemiol; 2003 Oct; 13(9 Suppl):S122-8. PubMed ID: 14575944
[No Abstract] [Full Text] [Related]
9. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
Dick SE; DeWitt DE; Anawalt BD
Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
[TBL] [Abstract][Full Text] [Related]
10. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
[No Abstract] [Full Text] [Related]
11. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
12. [The story of the reversal of opinion about hormone replacement therapy and cardiovascular disease].
Løkkegaard EC
Ugeskr Laeger; 2005 Mar; 167(10):1166-70. PubMed ID: 15810574
[No Abstract] [Full Text] [Related]
13. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
Mikkola TS; Clarkson TB; Notelovitz M
Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy. An update on risks and benefits.
Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
[No Abstract] [Full Text] [Related]
16. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
Henriksson P
Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
[No Abstract] [Full Text] [Related]
17. Postmenopausal hormone replacement therapy for the primary prevention of chronic condition. Recommendations and rationale. U.S. Preventive Services Task Force.
USPSTF
Am Fam Physician; 2003 Jan; 67(2):358-64. PubMed ID: 12562158
[No Abstract] [Full Text] [Related]
18. Soy foods for breast cancer survivors and women at high risk for breast cancer?
Maskarinec G
J Am Diet Assoc; 2005 Oct; 105(10):1524-8. PubMed ID: 16183350
[No Abstract] [Full Text] [Related]
19. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
20. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
Licznerska BE; Baer-Dubowska W
Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
